TOTAL-BODY CLEARANCE OF INFUSIONAL 5-FLUOROURACIL (5FU)

被引：0
|
作者：
FLOYD, R
GRIFFITHS, J
HORNBECK, C
FRANKEL, S
SHARP, T
BYFIELD, J
机构：
[1] VET ADM,MED CTR,SAN DIEGO,CA 92161
[2] UNIV SO CALIF,LOS ANGELES,CA 90033
[3] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [11] The mismatch repair (MMR) complex hMutSα recognizes 5-fluorouracil (5FU) modified DNA:: a mechanism for 5FU sensitivity
    Tajima, A
    Cabrera, BL
    McMahon, H
    Doctolero, R
    Huang, S
    Carethers, J
    GASTROENTEROLOGY, 2003, 124 (04) : A21 - A21
  • [12] Adjuvant therapy with 5-fluorouracil (5FU) plus levamisole or 5FU plus radiotherapy in resected colorectal cancer.
    Aparicio, J
    Segura, A
    Santaballa, A
    Garcerá, S
    Yuste, A
    López, P
    Tormo, A
    Reynés, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [13] ENZYMATIC CHANGES INDUCED BY THYMIDINE (TDR) AND 5-FLUOROURACIL (5FU) THERAPY
    SALSER, JS
    MARTIN, DS
    BALIS, ME
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 80 - 80
  • [14] Adsorption and Release of 5-Fluorouracil (5FU) from Mesoporous Silica Nanoparticles
    Azali, Nur Syazaliyana
    Kamarudin, Nur Hidayatul Nazirah
    Rahim, Ainul Rasyidah Abdul
    Nasir, Norzaidhatul Syifa'a Jamal
    Timmiati, Sharifah Najiha
    Jaafar, Nur Farhana
    MATERIALS TODAY-PROCEEDINGS, 2019, 19 : 1722 - 1729
  • [15] REGIONAL CHEMOTHERAPY TO THE CANINE LIVER WITH 5-FLUOROURACIL (5FU) AND ADRIAMYCIN (AM)
    KARAKOUSIS, CP
    SHARMA, SD
    KANTER, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 211 - 211
  • [16] LEVELS OF 5-FLUOROURACIL (5FU) IN PLASMA OF PATIENTS TREATED BY DRUG INFUSION
    HILLCOAT, BL
    MCCULLOCH, PB
    FIGUEREDO, A
    ROSENFELD, J
    KAWAI, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 199 - 199
  • [17] SEQUENTIAL METHOTREXATE (MTX) AND 5-FLUOROURACIL (5FU) IN ADENOCARCINOMA OF THE COLON AND RECTUM
    DRAPKIN, R
    GRIFFITHS, E
    MCALOON, E
    PALADINE, W
    SOKOL, G
    LYMAN, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 453 - 453
  • [18] INHIBITION OF ACONITASE (AC) ACTIVITY BY 5-FLUOROURACIL (5FU) AND METABOLITES IN THE RAT
    HUTSON, PR
    GRALINSKI, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 144 - 144
  • [19] EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS
    ELLIS, PA
    NORMAN, A
    HILL, A
    OBRIEN, MER
    NICHOLSON, M
    HICKISH, T
    CUNNINGHAM, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1594 - 1598
  • [20] PROGRESSIVE ACCUMULATION OF 5-FLUOROURACIL (FU) DURING CONTINUOUS INFUSIONAL THERAPY
    FLOYD, R
    HORNBECK, C
    BYFIELD, J
    FRANKEL, S
    SHARP, T
    CLINICAL RESEARCH, 1982, 30 (02): : A632 - A632
12345